TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

Revised diagnostic criteria for myeloid neoplasms (MN) issued by the International Consensus Classification (ICC) and the World Health Organization (WHO) recommended major change pertaining to TP53-mutated (TP53(mut)) MN. However, these assertions have not been specifically examined in therapy-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Mithun Vinod, Tran, Elizabeth Ngoc Hoa, Shah, Syed, Chhetri, Rakchha, Baranwal, Anmol, Ladon, Dariusz, Shultz, Carl, Al-Kali, Aref, Brown, Anna L., Chen, Dong, Scott, Hamish S., Greipp, Patricia, Thomas, Daniel, Alkhateeb, Hassan B., Singhal, Deepak, Gangat, Naseema, Kumar, Sharad, Patnaik, Mrinal M., Hahn, Christopher N., Kok, Chung Hoow, Tefferi, Ayalew, Hiwase, Devendra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090194/
https://www.ncbi.nlm.nih.gov/pubmed/37041128
http://dx.doi.org/10.1038/s41408-023-00821-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090194/
https://www.ncbi.nlm.nih.gov/pubmed/37041128
http://dx.doi.org/10.1038/s41408-023-00821-x

Ejemplares similares